Scientists test swine flu vaccine safety for expectant mothers
NCT ID NCT01024400
Summary
This study tested a specific H1N1 flu vaccine in pregnant women to see if it safely triggered a protective immune response. It involved about 110 women who were between 22 and 32 weeks pregnant. Researchers gave two vaccine doses and monitored the women's health and immune system reactions to ensure safety for both mother and baby.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Besançon-Hôpital Saint-Jacques
Besançon, 25030, France
-
Groupe hospitalier Cochin Saint Vincent de Paul
Paris, 75679, France
-
Hôpital Antoine Béclère
Clamart, 92141, France
-
Hôpital Robert Debré
Paris, 75935, France
-
Hôpital Sud de Rennes
Rennes, 35056, France
Conditions
Explore the condition pages connected to this study.